(Q46722608)

English

Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice

scientific article published on 26 September 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16186601

Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice (English)

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16186601

atherosclerosis

1 reference

based on heuristic

inferred from title

author name string

Elyisha A Hanniman

1

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16186601

Gilles Lambert

2

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16186601

Tanya C McCarthy

3

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16186601

Christopher J Sinal

4

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16186601

publication date

26 September 2005

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16186601

Journal of Lipid Research

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16186601

46

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16186601

2595-2604

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16186601

12

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16186601

Atherosclerosis

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

Nuclear receptors and the control of metabolism

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

Liver X Receptor Signaling Pathways in Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

PPARs and LXRs: atherosclerosis goes nuclear

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

PPARs: therapeutic targets for metabolic disease

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

The farnesoid X receptor induces very low density lipoprotein receptor gene expression

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

Regulation of carbohydrate metabolism by the farnesoid X receptor

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

Glucose regulates the expression of the farnesoid X receptor in liver

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

The hypolipidemic natural product guggulsterone acts as an antagonist of the bile acid receptor

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

A natural product that lowers cholesterol as an antagonist ligand for FXR.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

The farnesoid X-receptor is an essential regulator of cholesterol homeostasis

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

Identification of a chemical tool for the orphan nuclear receptor FXR.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

Vitamin D receptor-dependent regulation of colon multidrug resistance-associated protein 3 gene expression by bile acids

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

Hepatic (dys-)function during inflammation

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

Apolipoprotein E and atherosclerosis

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

Tumor necrosis factor: an apoptosis JuNKie?

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

Expression of nuclear receptors and apo E secretion during the differentiation of monocytic THP-1 cells into macrophages

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

Prevention of cholesterol gallstone disease by FXR agonists in a mouse model.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

The hypolipidemic natural product guggulsterone is a promiscuous steroid receptor ligand

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

Guggulsterone activates multiple nuclear receptors and induces CYP3A gene expression through the pregnane X receptor

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500390-JLR200

21 January 2018

Identifiers

10.1194/JLR.M500390-JLR200

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16186601

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16186601

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46722608&oldid=2128419256"